查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球組織處理系統市場 - 2023-2030
市場調查報告書
商品編碼
1345379

全球組織處理系統市場 - 2023-2030

Global Tissue Processing Systems Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球組織處理系統市場在 2022 年達到 3.832 億美元，預計到 2030 年將達到 5.786 億美元，2023-2030 年預測期間年複合成長率為 5.4%。全球組織加工系統市場受到多種因素的推動，例如人口老齡化的增加、生活方式疾病的增加、技術的進步以及政府不斷採取的措施，以提供方便和高品質的醫療保健選擇。

組織處理涉及將固定的動物或人體組織轉移到切片機中進行組織學蠟植入和切片切割。它涉及去除細胞中的水並用冷凍培養基代替以製成薄片。經過適當的修復後，組織會經歷脫水、清潔和滲透。

組織學實驗室的組織處理包括準備用於疾病診斷的身體組織，以及製作供病理學家在顯微鏡下觀察的顯微載玻片，技術包括活體組織切片、手術標本和屍檢組織。組織技術專家處理組織處理和玻璃顯微鏡載玻片。

市場動態

癌症患病率上升

癌症患病率的上升是預測期內幫助市場成長的關鍵因素之一。組織處理系統廣泛應用於癌症診斷實驗室。活體組織切片樣本在組織處理器中進行處理以進行癌症診斷。他們可以管理大量樣品、快速處理樣品並產生高品質的結果。

這些系統在製備和處理用於病理檢查、診斷和研究的組織樣本方面發揮著至關重要的作用。隨著對準確、高效的癌症診斷和治療的需求不斷成長，組織處理系統成為實驗室和醫療機構的重要工具。

例如，根據美國癌症協會的數據，預計 2023 年美國將新增 1,958,310 例癌症病例，約 609,820 人死於癌症，即每天約 1,670 人死亡。癌症是美國第二大常見死因，僅次於心臟病。

技術進步的崛起

近年來，組織處理程序得到了顯著改進。組織處理機自動化具有多種優勢，包括改善流體循環、節省時間和溫度控制。自動化組織處理機的其他優點包括大大增強的組織處理、自動清潔循環和試劑管理系統。此外，它有助於減少人為錯誤。這提高了技術先進的組織加工機的可接受性，從而增加了對組織加工設備的需求。

缺乏訓練有素的專業人員

組織處理系統市場訓練有素的專業人員短缺是由於專業技能、教育計劃以及對醫學研究、診斷和生物技術專家不斷成長的需求等因素造成的。組織處理機、切片機和染色機等設備的複雜性進一步限制了熟練從業人員的數量。

為了解決這個問題，需要學術界、工業界和專業組織之間的合作，包括專業教育、專業發展投資、公眾意識、研究合作以及學徒和實習計劃。

有關此報告的更多詳細資訊 - 索取樣品

目錄

第 1 章：方法和範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義和概述

第 3 章：執行摘要

  • 按產品分類
  • 按模態分類
  • 技術片段
  • 最終用戶的片段
  • 按地區分類

第 4 章：動力學

  • 影響因素
    • 動力
      • 癌症患病率上升
      • 技術進步的崛起
    • 限制
      • 缺乏訓練有素的專業人員
    • 機會
      • 個性化醫療日益受到關注
    • 影響分析

第 5 章：行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情況
    • COVID-19 期間的情況
    • Covid-19 後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商戰略舉措
  • 結論

第 7 章：副產品

  • 小容量組織處理機
  • 中等容量組織處理機
  • 大容量組織處理機

第 8 章：按形態

  • 台式組織處理裝置
  • 攜帶式組織處理裝置

第 9 章：按技術

  • 微波組織處理機
  • 真空組織處理機

第 10 章：最終用戶

  • 醫院
  • 學術及研究機構
  • 診斷實驗室
  • 其他

第 11 章：按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
      • 亞太其他地區
  • 中東和非洲
    • 關鍵地區特定動態

第 12 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章：公司簡介

  • Danaher(Leica Biosystems Nussloch GmbH)
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • JOKOH
  • Medite Medical GmbH
  • Milestone SRL
  • Sakura Finetek USA, Inc.
  • SLEE medical GmbH
  • Bio Optica
  • Histo-Line Laboratories
  • General Data Company Inc
  • Unimeditrek

第 14 章：附錄

簡介目錄
Product Code: MD6745

Market Overview

Global Tissue Processing Systems Market reached US$ 383.2 million in 2022 and is expected to reach US$ 578.6 million by 2030 growing with a CAGR of 5.4% during the forecast period 2023-2030. The global tissue processing systems market is driven by various factors like an increase in the ageing population, an rise in lifestyle diseases, technological advancements, and rising government initiatives to provide accessible and high-quality healthcare options.

Tissue processing involves transferring fixed animal or human tissue to a microtome for histological wax implantation and section cutting. It involves removing water from cells and replacing it with frozen media for thin slices. After proper repair, the tissue undergoes dehydration, cleansing and infiltration.

Tissue processing in the histology laboratory involves preparing body tissues for disease diagnosis and producing microscopic slides for pathologists to view under a microscope and techniques include biopsies, surgical specimens, and autopsy tissues. Histotechnologists handle tissue processing and glass microscopic slides.

Market Dynamics

Rise in the Prevalence of Cancer Diseases

The rise in the prevalence of cancer is one of the key factors that helps the market to grow during the forecast period. Tissue processing systems are widely used in cancer diagnostic laboratories. Biopsy samples are processed in tissue processors for cancer diagnosis. They can manage a large number of samples, quickly process the samples, and produce high-quality results.

These systems play a crucial role in preparing and processing tissue samples for pathological examination, diagnosis, and research. As the need for accurate and efficient cancer diagnosis and treatment grows, tissue processor systems become essential tools for laboratories and healthcare facilities.

For instance, according to American Cancer Society data, in 2023 there are projected to be 1,958,310 new cancer cases and approximately 609,820 deaths from cancer are expected in the US in 2023 which is about 1,670 deaths per day. Cancer is the second most common cause of death in the US, exceeded only by heart disease.

Rise in Technological Advancements

Tissue processing procedures have been considerably improved in recent years. Tissue processor automation has several advantages, including improved fluid circulation, time savings, and temperature control. Other advantages of automated tissue processors include greatly enhanced tissue processing, automatic cleaning cycles, and reagent management systems. Furthermore, it aids in the reduction of human mistakes. This raises the acceptability of technologically sophisticated tissue processors, hence increasing demand for tissue processing equipment.

Lack of Trained Professionals

The shortage of trained professionals in the tissue processing systems market is due to factors like specialized skill sets, educational programs, and the growing demand for experts in medical research, diagnostics, and biotechnology. The intricate nature of equipment, such as tissue processors, microtomes, and staining machines, further limits the pool of skilled practitioners.

To address this issue, collaboration between academia, industry, and professional organizations is needed, including specialized education, investment in professional development, public awareness, research collaborations, and apprenticeship and internship initiatives.

For more details on this report - Request for Sample

Segment Analysis

The global tissue processing systems market is segmented based on product type, modality, technology, end user and region.

The Small Volume Tissue Processors From The Product Segment Accounted for Approximately 42.1 % of the Tissue Processing Systems Market Share

The small volume of tissue processors from the product segment with around 42.1% is expected to dominate during the forecast period. These are suitable for small laboratory sizes as well as also save space the factors supporting its demand and growth in the market. For instance, the Leica TP1020 semi-enclosed rotary processor is designed for reliability and economy. It can optimize laboratory space with the small footprint of the HistoCore PEARL tissue processor. It is a semi-enclosed benchtop tissue processor with small volumes (≤200 blocks/day).

Geographical Penetration

North America Accounted for Approximately 37.9% of the Market Share in 2022

North America is estimated to hold about 37.9% of the total market share throughout the forecast period, due to the launches of new tissue processors, technological advancements, expansion by key players, growing geriatric population along with adoption of innovative medical technology, rise in cancer incidence, and raising awareness about cancer screening in this region.

For instance, on 3rd February 2022, Leica Biosystems expanded its Dual-Retort Tissue Processor portfolio in North America with HistoCore PEGASUS. The main issue with tissue processing is processing biopsy and large routine specimens in the same run, causing under- or over-processing. In ideal scenarios, biopsy and larger sample tissues should be processed separately using a specific protocol.

Competitive Landscape

The major global players in the tissue processing systems market include JOKOH, Danaher(Leica Biosystems Nussloch GmbH), Medite Medical GmbH, Milestone SRL, Sakura Finetek USA, Inc., SLEE medical GmbH, Bio Optica, Histo-Line Laboratories, General Data Company Inc, Unimeditrek and among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the histology equipment industry, limiting demand for slide staining and tissue processing systems. Clinical testing providers face logistical challenges such as transportation of tissue samples, access to microscopes, and IT systems. However, companies like Roche Digital Pathology have made decisive steps to overcome these challenges, offering a comprehensive solution for chronic illness diagnosis. This will likely significantly influence the worldwide tissue processing systems market.

Russia Ukraine Conflict Analysis

The Russia-Ukraine war significantly impacted the tissue processing systems market, causing supply chain disruptions and increased raw material costs. Sanctions from several countries cut supply while rising inflation presents new challenges for manufacturers.

By Product Type

  • Small-volume tissue processors
  • Medium Volume tissue processors
  • High Volume tissue processors

By Modality

  • Bench Top tissue processing unit
  • Portable tissue processing unit

By Technology

  • Microwave tissue processors
  • Vaccum tissue processors

By End User

  • Hospitals
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Others

By Region

  • North America

U.S.

Canada

Mexico

  • Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

  • South America

Brazil

Argentina

Rest of South America

  • Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

  • Middle East and Africa

Key Developments

  • In March 2023, Virscio, a leading provider of translational research and development services, launched a new Pathology and Tissue Pharmacodynamics Division to enhance preclinical drug development programs. The division, led by Dr Jennifer Cann and Richard Bouffard, offers comprehensive non-GLP, GLP, and GCLP histology and pathology services, including tissue processing, slide preparation, staining, immunohistochemistry, digital slide scanning, quantitative image analysis, and pathology interpretation.
  • In September 2022, the histopathology company Sakura Finetek Europe announced the launch of its newest solution Tissue-Tek Genie, an advanced staining system, entering the market.
  • In September 2020, Sakura Finetek USA, Inc. announced the launch of two new laser-printable tissue cassettes, broadening the Tissue-Tek Paraform Sectionable Cassette System for use on the Tissue-Tek AutoTEC a120 Automated Embedding Systems.

Why Purchase the Report?

  • To visualize the global tissue processing systems market segmentation based on product type, modality, technology, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of tissue processing systems market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global tissue processing systems market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Modality
  • 3.3. Snippet by Technology
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in the Prevalence of Cancer Diseases
      • 4.1.1.2. Rise in Technological Advancements
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Trained Professionals
    • 4.1.3. Opportunity
      • 4.1.3.1. Rise in Focus on Personalized Medicine
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Small Volume Tissue Processors *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Medium Volume Tissue Processors
  • 7.4. High Volume Tissue Processors

8. By Modality

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.1.2. Market Attractiveness Index, By Modality
  • 8.2. Bench Top Tissue Processing Unit*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Portable Tissue Processing Unit

9. By Technology

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.1.2. Market Attractiveness Index, By Technology
  • 9.2. Microwave Tissue Processors *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Vaccum Tissue Processors

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Academic and Research Institutes
  • 10.4. Diagnostic Laboratories
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Danaher(Leica Biosystems Nussloch GmbH)*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. JOKOH
  • 13.3. Medite Medical GmbH
  • 13.4. Milestone SRL
  • 13.5. Sakura Finetek USA, Inc.
  • 13.6. SLEE medical GmbH
  • 13.7. Bio Optica
  • 13.8. Histo-Line Laboratories
  • 13.9. General Data Company Inc
  • 13.10. Unimeditrek

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us